Sarilumab
Sanofi,regeneron
[]
spiera et al. sarilumab in refractory pmr (saphyr) - phase 3 rct. significant effect of il-6i. #acr22 abstr#1676 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC